KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
24,50 USD
0,00%
(0,00) 1D
1-окт., 10:21:43 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KSPHF...
Mkt. cap
176,63 млд
Avg. vol.
20,00
Volume
0,00
52-wk high
31,90 USD
52-wk low
24,50 USD
Beta
13,94
Shares outstanding
46,54 млн
No. of employees
2 миң
Mkt. cap
176,63 млд
Avg. vol.
20,00
Volume
0,00
52-wk high
31,90 USD
52-wk low
24,50 USD
Beta
13,94
Shares outstanding
46,54 млн
No. of employees
2 миң
News stories
From web sources and news partners
Watauga Democrat
·
34 мүнөт мурун
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales and Shipments of 1.4 Million Gallons of Renewable Diesel in September
24/7 Wall St.
·
51 мүнөт мурун
Buffett Says a Know-Nothing Investor Can Beat the Pros. $250 a Month in the S&P 500 Could Turn Into $508,000
Myrtle Beach Sun News
·
1 саат мурун
S&P 500, Dow futures muted after big bank earnings, chip slide weighs
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1,79 миң
Founded1946-ж., 9-авг.
HeadquartersMatsumoto, Nagano, Япония
SectorPharmaceutical industry
Websitekissei.co.jp